Trade Ideas March 4, 2026

Celestica Pullback: Why Extended Consolidation Is a Tactical Buying Window

High free cash flow, AI-tailored product wins and a buyback create an asymmetric risk/reward around $260

By Ajmal Hussain CLS
Celestica Pullback: Why Extended Consolidation Is a Tactical Buying Window
CLS

Celestica shares have spent months carving out a base after a sharp run-up in 2025. Fundamentals - including $458M in free cash flow, a strong ROE and an enterprise value near $29.7B - give buyers a reason to act. This trade idea lays out a mid-term swing entry, precise risk controls and the catalysts that can reprice the stock higher if order momentum returns.

Key Points

  • Celestica generates solid free cash flow ($458.3M) and has a strong ROE (~37.6%), giving optionality to buybacks and reinvestment.
  • New product SD6300 targets AI/storage density - if adopted, it improves mix and supports a re-rating.
  • Current technicals show consolidation with RSI ~35 and price below short/medium SMAs - a tactical entry band for disciplined buyers.
  • Valuation is rich on P/E (~35) but supported if order/margin momentum returns; downside is guarded with a defined stop at $235.

Hook / Thesis

Celestica (CLS) has done the boring work: high-margin pockets inside its Advanced Technology Solutions and Connectivity and Cloud Solutions segments, a recent product push into density-optimized server platforms, and a sizable free cash flow stream. Yet the market has punished the stock from its $363 52-week high into the mid-$200s and left it trading below most of its short- and medium-term moving averages. That prolonged consolidation is a tactical gift for disciplined buyers willing to size risk and hold through a rotation back into AI/data-center suppliers.

My thesis: buy a mid-term swing around $255–$260 because the business generates real cash ($458.3M free cash flow last reported), has a clean balance sheet (debt-to-equity ~0.35), and just introduced an AI/storage-focused product (SD6300) that maps directly to strong secular demand. The technical backdrop (RSI ~35, MACD negative but stabilizing) and a recently accepted Normal Course Issuer Bid increase the asymmetric upside if orders re-accelerate.

What Celestica does and why it matters

Celestica is a global provider of supply-chain and electronics manufacturing services to equipment manufacturers and service providers. It operates two segments: Advanced Technology Solutions (ATS) - which covers aerospace & defense, smart energy, health tech and industrial - and Connectivity & Cloud Solutions (CCS) - which covers enterprise communications, telecom, servers and storage. The company is positioning itself to capture a greater share of AI and enterprise storage buildouts through platforms like the SD6300, explicitly designed for maximum storage density in enterprise and AI applications.

The market should care because Celestica sits at the intersection of two high-growth vectors: secular IT infrastructure demand (servers, storage) and specialized manufacturing for high-value customers. The firm’s financials show that the business is profitable and cash generative: return on equity near 37.6%, free cash flow of $458.3M and an enterprise value of roughly $29.7B. For a capital-intensive electronics manufacturer, those are meaningful strengths.

Hard numbers that support the trade

  • Current stock price: $260 (snapshot).
  • Market cap: about $29.55B; enterprise value: ~$29.70B.
  • Free cash flow: $458.3M - a visible cash engine for buybacks or reinvestment.
  • Profitability: EPS ~$7.25 and a P/E roughly 35.5; ROE ~37.6%.
  • Valuation ratios: price-to-sales ~2.38 and EV/EBITDA ~23.8.
  • Technicals: 10/20/50-day SMAs are all above current price, RSI ~35.7 (leans toward oversold), MACD shows bearish momentum but with a narrowing histogram.
  • Share dynamics: outstanding float ~113.7M shares, short interest has been variable but days-to-cover sits near 1 — short squeezes can be fast but short interest alone doesn’t imply material structural pressure.

Put simply: the business generates cash, management can buy back stock (NCIB accepted), and product launches target a big addressable market (AI/data center). Those are the ingredients for a re-rating if orders and margins hold or improve.

Valuation framing

At a market cap near $29.6B and an EV of ~$29.7B, Celestica is not cheap on headline multiples: P/E near 35 and EV/EBITDA about 24. That premium partly reflects expectations that the company will monetize higher-value system integration and data-center assembly work - areas with higher margins versus commodity board assembly.

Compare that to Celestica's own history: the stock hit a $363 52-week high in 2025 and traded at elevated multiples when growth expectations were peaking. The pullback toward $260 has trimmed some of that optimism. If Celestica converts product wins like the SD6300 into sustained order flow, the current multiples look supportable. If not, the valuation becomes harder to justify and downside risk grows.

Catalysts (2-5)

  • Data center order announcements / design wins for SD6300 or related platforms - will show commercial traction for the new product.
  • Quarterly results re-acceleration in bookings and margin expansion - demonstrates improved mix toward higher-margin assemblies.
  • NCIB execution and buyback announcements - reduces supply and supports EPS if management follows through.
  • Macro pickup in server/storage capex tied to AI and enterprise modernization - a broader tailwind that benefits CCS revenue.

Trade plan (actionable)

Below is a focused swing trade with defined entry, stop and target. Size this position relative to your portfolio risk tolerance; the setup is not intended for full allocation purchases.

Action Price Horizon
Entry $255.00 Mid term (45 trading days)
Stop Loss $235.00
Target $300.00

Rationale: enter near $255 to capture consolidation support around recent intraday opens. The stop at $235 limits downside to a level which, if broken, would imply the base failed and the technical momentum remains negative. The $300 target is reachable if order flow or margin commentary re-accelerates, and it represents a sensible first profit-taking area where the stock would be approaching recent moving averages and regain part of its prior premium.

Why mid term (45 trading days)?

This is a mid-term swing because product adoption cycles and order-book updates typically show up across one to two quarters. Forty-five trading days gives the company time to report order momentum and gives the market a window to re-assess the multiple as near-term cash generation and backlog trends become clearer.

Risks and counterarguments

There are credible reasons this consolidation could persist or worsen. A fair assessment must include them:

  • Loss of a major customer or order cuts. Recent headlines have flagged investor concerns that Google may shift TPU assembly away from Celestica. On 02/17/2026 a law firm announced an investigation into Celestica following those reports. Losing or shrinking a big hyperscaler relationship would materially reduce revenue and re-rate the multiple lower.
  • Valuation vulnerability. A P/E near 35 and EV/EBITDA around 24 imply high expectations. If margin expansion stalls, the stock can give back significant value quickly.
  • Cyclical end markets. Server and telecom capex are cyclical. A macro slowdown or a pause in AI infrastructure spending would hurt orders and utilization, pressuring profits.
  • Competition and customer concentration. Celestica competes with other EMS and ODM providers. Customer consolidation or preferred-supplier shifts can change future revenue mix.
  • Legal and reputational risk. The investor litigation inquiry tied to customer shifts increases headline volatility and could distract management or create contingent liabilities.

Counterargument to my thesis: the market’s caution may be justified. If key hyperscalers diversify suppliers and order volumes normalize below current expectations, Celestica’s premium multiples will compress. In that scenario the stock could revisit lower technical support bands and the buyback may not be enough to offset fundamental deterioration.

What would change my mind

I will reconsider or reverse the trade if any of the following happen:

  • Company guidance for bookings and revenue declines materially on the next quarterly call, showing lost business from hyperscalers.
  • Management abandons or scales back the NCIB and we see consistent deterioration in free cash flow or a meaningful rise in net debt beyond current debt-to-equity ~0.35.
  • Technicals break down decisively below $235 on high volume, which would invalidate the current consolidation thesis.

Conclusion

Celestica’s consolidation around $255–$260 is a favorable entry for a mid-term swing. The company’s free cash flow, ROE and product focus for AI/storage markets provide a credible fundamental base for upside if order momentum returns. The trade is not without risk: customer concentration, legal headlines and a still-elevated multiple mean the margin for error is limited. Use disciplined sizing, a $235 stop and the $300 target as the first profit-taking point. If Celestica prints stronger bookings or demonstrates SD6300 traction in the next 45 trading days, the reward profile looks constructive from here.

Trade idea: Buy at $255.00, stop $235.00, target $300.00 - mid term (45 trading days).

Risks

  • Potential loss or reduction of business from a major hyperscaler (news and investigator activity reported 02/17/2026).
  • High multiples (P/E ~35, EV/EBITDA ~24) leave little room for earnings disappointment.
  • Cyclicality in server/storage capex could depress orders if macro or enterprise spend slows.
  • Investor litigation and headline risk can increase volatility and distract management from execution.

More from Trade Ideas

DoorDash Is Back on the Offense: Order Acceleration Looks Real, Set Up for a Mid-Run Upside Mar 22, 2026 Standard Motor Products: Buy the Dip — a Mid‑Swing Trade Backing a Cheap, Cash‑Paying Aftermarket Play Mar 22, 2026 Buy the Pullback: Nvidia's AI Leadership Still Deserves a Premium Mar 22, 2026 Buy PAA for Yield and Crude Exposure: High Income, Reasonable Valuation, Tactical Entry Now Mar 22, 2026 Buy-the-Dip Setup in Novartis: Synnovation Deal and Durable Growth Make $NVS a Tactical Long Mar 22, 2026